119-hres675

HRES
✓ Complete Data

Expressing support for the designation of September 2025 as "National Prostate Cancer Awareness Month".

Login to track bills
Introduced:
Sep 3, 2025
Policy Area:
Health

Bill Statistics

3
Actions
6
Cosponsors
0
Summaries
1
Subjects
1
Text Versions
Yes
Full Text

AI Summary

No AI Summary Available

Click the button above to generate an AI-powered summary of this bill using Claude.

The summary will analyze the bill's key provisions, impact, and implementation details.

Latest Action

Sep 3, 2025
Referred to the House Committee on Energy and Commerce.

Actions (3)

Referred to the House Committee on Energy and Commerce.
Type: IntroReferral | Source: House floor actions | Code: H11100
Sep 3, 2025
Submitted in House
Type: IntroReferral | Source: Library of Congress | Code: H11100
Sep 3, 2025
Submitted in House
Type: IntroReferral | Source: Library of Congress | Code: 1025
Sep 3, 2025

Subjects (1)

Health (Policy Area)

Cosponsors (4 of 6)

Showing latest 4 cosponsors

Text Versions (1)

Introduced in House

Sep 3, 2025

Full Bill Text

Length: 4,295 characters Version: Introduced in House Version Date: Sep 3, 2025 Last Updated: Nov 15, 2025 6:01 AM
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 675 Introduced in House

(IH) ]

<DOC>

119th CONGRESS
1st Session
H. RES. 675

Expressing support for the designation of September 2025 as ``National
Prostate Cancer Awareness Month''.

_______________________________________________________________________

IN THE HOUSE OF REPRESENTATIVES

September 3, 2025

Mr. Carter of Louisiana (for himself, Mr. McCormick, Mr. Dunn of
Florida, Mr. Lieu, and Mr. Menendez) submitted the following
resolution; which was referred to the Committee on Energy and Commerce

_______________________________________________________________________

RESOLUTION

Expressing support for the designation of September 2025 as ``National
Prostate Cancer Awareness Month''.

Whereas more than 3,100,000 men have at some point been diagnosed with prostate
cancer and are still alive in the United States;
Whereas 1 in 8 men in the United States will be diagnosed with prostate cancer
in their lifetimes and 1 in 44 men in the United States will die from
prostate cancer;
Whereas the Men's Health Network advises that prostate cancer is the most
commonly diagnosed nonskin cancer and the second-leading cause of
cancer-related deaths among men in the United States;
Whereas the American Cancer Society estimates that, in 2025, 313,780 men will be
diagnosed with, and more than 35,770 men will die of, prostate cancer;
Whereas 40 percent of newly diagnosed prostate cancer cases occur in men under
the age of 65;
Whereas the odds of developing prostate cancer rise rapidly after age 50;
Whereas African-American men suffer from a prostate cancer incidence rate that
is significantly higher than that of White men and have more than double
the prostate cancer mortality rate than that of White men;
Whereas having a father or brother with prostate cancer more than doubles the
risk of a man developing prostate cancer, with a higher risk for men who
have a brother with the disease and the highest risk for men with
several affected relatives;
Whereas screening by a digital rectal examination and a prostate-specific
antigen blood test can detect the disease at the earlier, more treatable
stages, which could increase the chances of survival for more than 5
years to nearly 100 percent;
Whereas only 32 percent of men survive more than 5 years if diagnosed with
prostate cancer after the cancer has metastasized;
Whereas there are typically no noticeable symptoms of prostate cancer in the
early stages, making appropriate screening critical;
Whereas the Department of Veterans Affairs has established 21 Precision Oncology
Centers of Excellence in order to deliver precision oncology services to
veterans suffering from prostate cancer;
Whereas ongoing research promises further improvements in prostate cancer
prevention, early detection, and treatment; and
Whereas educating people in the United States, including health care providers,
about prostate cancer and early detection strategies is crucial to
saving the lives of men and preserving and protecting families: Now,
therefore, be it
Resolved, That the House of Representatives--

(1) expresses support for the designation of ``National
Prostate Cancer Awareness Month'';

(2) declares that steps should be taken--
(A) to raise awareness about the importance of
screening methods for, and treatment of, prostate
cancer;
(B) to encourage research--
(i) to improve screening and treatment for
prostate cancer;
(ii) to discover the causes of prostate
cancer; and
(iii) to develop a cure for prostate
cancer; and
(C) to continue to consider ways to improve access
to, and the quality of, health care services for
detecting and treating prostate cancer; and

(3) calls on the people of the United States, interest
groups, and affected persons--
(A) to promote awareness of prostate cancer;
(B) to take an active role in the fight to end the
devastating effects of prostate cancer on individuals,
families, and the economy; and
(C) to observe National Prostate Cancer Awareness
Month with appropriate ceremonies and activities.
<all>